LSU BE, ChE Team Study Drug Resistance in ER+ Breast Cancer Cells
October 28, 2021
October 28, 2021
BATON ROUGE, Louisiana, Oct. 28 (TNSRes) -- Louisiana State University issued the following news release on Oct. 27, 2021:
Estrogen receptor-positive (ER+) breast cancer is the most common type of breast cancer diagnosed today. When someone has ER+ breast cancer, the cancer cells' growth is facilitated by the estrogen receptor. In breast cancer, hormone receptors (proteins located in and around breast cells) signal cancerous cells to grow uncontrollably, resulting in a tumor.
Estrogen receptor-positive (ER+) breast cancer is the most common type of breast cancer diagnosed today. When someone has ER+ breast cancer, the cancer cells' growth is facilitated by the estrogen receptor. In breast cancer, hormone receptors (proteins located in and around breast cells) signal cancerous cells to grow uncontrollably, resulting in a tumor.